We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.3%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTE icon
1826
Gran Tierra Energy
GTE
$317M
$34K ﹤0.01%
2,161
-2,499
-54% -$53.2K
HSBC icon
1827
HSBC
HSBC
$356B
$34K ﹤0.01%
793
-1,247
-61% -$52.2K
KSS icon
1828
Kohl's
KSS
$2.19B
$34K ﹤0.01%
709
-5,350
-88% -$323K
MKC.V icon
1829
McCormick & Company Voting
MKC.V
$14.2B
$34K ﹤0.01%
434
+352
+429% +$27.1K
PGX icon
1830
Invesco Preferred ETF
PGX
$3.78B
$34K ﹤0.01%
2,319
+2,220
+2,242% +$32.4K
PHI icon
1831
PLDT
PHI
$4.33B
$34K ﹤0.01%
+1,353
New +$32.2K
TAK icon
1832
Takeda Pharmaceutical
TAK
$55.7B
$34K ﹤0.01%
1,898
+1,858
+4,645% +$33.8K
MMAC
1833
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$34K ﹤0.01%
+1,013
New +$32.5K
BT
1834
DELISTED
BT Group plc (ADR)
BT
$34K ﹤0.01%
+2,633
New +$36.6K
ALEX
1835
DELISTED
Alexander & Baldwin
ALEX
$33K ﹤0.01%
+1,407
New +$33.4K
AMCR icon
1836
Amcor
AMCR
$22.1B
$33K ﹤0.01%
+577
New +$32K
CGBD icon
1837
Carlyle Secured Lending
CGBD
$758M
$33K ﹤0.01%
2,198
+1,445
+192% +$21.6K
GIB icon
1838
CGI
GIB
$15.5B
$33K ﹤0.01%
431
+113
+36% +$8.21K
HNNA icon
1839
Hennessy Advisors
HNNA
$78.5M
$33K ﹤0.01%
3,447
+1,515
+78% +$14.5K
IMUX icon
1840
Immunic
IMUX
$195M
$33K ﹤0.01%
291
+197
+210% +$25.9K
MD icon
1841
Pediatrix Medical
MD
$2.2B
$33K ﹤0.01%
1,323
-7,591
-85% -$204K
MITT
1842
TPG Mortgage Investment Trust
MITT
$225M
$33K ﹤0.01%
+694
New +$34.2K
RMT
1843
Royce Micro-Cap Trust
RMT
$761M
$33K ﹤0.01%
4,060
+3,519
+650% +$29.1K
VCTR icon
1844
Victory Capital Holdings
VCTR
$6.65B
$33K ﹤0.01%
+1,922
New +$31.7K
ONIT
1845
Onity Group
ONIT
$332M
$33K ﹤0.01%
+1,075
New +$28.7K
TA
1846
DELISTED
TravelCenters of America LLC
TA
$33K ﹤0.01%
1,798
-157
-8% -$3.01K
BXG
1847
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$33K ﹤0.01%
2,808
-18,947
-87% -$243K
FPRX
1848
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$33K ﹤0.01%
5,374
+5,074
+1,691% +$48.5K
ADNT icon
1849
Adient
ADNT
$1.5B
$32K ﹤0.01%
1,330
-3,457
-72% -$71.1K
ANIP icon
1850
ANI Pharmaceuticals
ANIP
$1.78B
$32K ﹤0.01%
+385
New +$27.4K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.